Join
Live feed
·
PRReleasevia Quantisnow
AlphaTON Capital Corp. logo

AlphaTON Capital Executes Binding Call Option to Sell Legacy Biotech Asset iOx Therapeutics to Immunova

ByQuantisnow·Wall Street's wire, on your screen.
ATON· AlphaTON Capital Corp.
Energy

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATON (AlphaTON Capital Corp.) and more on Quantisnow.